EXAS : Summary for Exact Sciences Corporation - Yahoo Finance

U.S. Markets open in 5 hrs 3 mins

Exact Sciences Corporation (EXAS)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
21.42-0.26 (-1.20%)
At close: 4:00PM EST
People also watch
EXELACADARRYSRPTCLDX
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close21.68
Open21.50
Bid17.80 x 100
Ask22.51 x 500
Day's Range21.05 - 21.87
52 Week Range4.67 - 23.68
Volume1,922,591
Avg. Volume2,636,127
Market Cap2.32B
Beta1.02
PE Ratio (TTM)-12.49
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Pfizer's Leukemia Candidate Gets Priority Review in U.S.
    Zacks4 days ago

    Pfizer's Leukemia Candidate Gets Priority Review in U.S.

    Pfizer Inc. (PFE) announced that its Biologics License Application (BLA) for leukemia candidate inotuzumab ozogamicin has been accepted for priority review by the FDA.

  • Investopedia5 days ago

    Is EXAS Getting Ahead of Itself?

    EXAS reported results for the fourth quarter and full year 2016, and gave upbeat guidance.

  • EXACT Sciences Corp. :EXAS-US: Earnings Analysis: Q4, 2016 By the Numbers : February 22, 2017
    Capital Cube5 days ago

    EXACT Sciences Corp. :EXAS-US: Earnings Analysis: Q4, 2016 By the Numbers : February 22, 2017

    Categories: Yahoo Finance Get free summary analysis EXACT Sciences Corp. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of EXACT Sciences Corp. – Myriad Genetics, Inc., Genomic Health, Inc. and Invacare Corporation (MYGN-US, GHDX-US and IVC-US) that have also reported for this period. Highlights Summary numbers: Revenues ... Read more (Read more...)